Showing results (81-90 of 142) with videos related to
Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08K K Fu, E Hammond, T F Pajak, et al.Cancer|April 3, 1999
Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology GroupS R Bonin, T F Pajak, A H Russell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's diseaseM R Cooper, T F Pajak, A J Gottlieb, et al.American Journal of Clinical Oncology|June 1, 1989
Chemotherapy following surgery for head and neck cancer. A Radiation Therapy Oncology Group StudyJ R Jacobs, T F Pajak, M al-Sarraf, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13J D Cox, T F Pajak, V A Marcial, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313J D Cox, T F Pajak, V A Marcial, et al.International Journal of Radiation Oncology, Biology, Physics|August 25, 2007
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)Mitchell Machtay, Thomas F Pajak, Mohan Suntharalingam, et al.International Journal of Radiation Oncology, Biology, Physics|January 11, 1991
Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG reportT F Pajak, G E Laramore, V A Marcial, et al.Cancer|January 15, 1987
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG StudyM Al-Sarraf, T F Pajak, V A Marcial, et al.Head & Neck|September 23, 1998
Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?J S Cooper, T F Pajak, A Forastiere, et al.Pageof 15